文献速递睡眠呼吸障碍

固定压力CPAP而非自动调节CPAP可减缓OSA患者肾小球滤过率随时间下降

Fixed But Not Autoadjusting Positive Airway Pressure Attenuates the Time-dependent Decline in Glomerular Filtration Rate in Patients With OSA.
PubMed 文献 · Chest · 2018-04-24

本研究基于欧洲睡眠呼吸暂停数据库前瞻性队列,比较未治疗、固定压力CPAP(fCPAP)和自动调节CPAP(APAP)对OSA患者估算肾小球滤过率(eGFR)的影响。结果显示全体样本eGFR随时间下降,基线eGFR高于中位数(91.42 mL/min/1.73 m2)者下降更显著;fCPAP治疗可减轻或消除该下降,而APAP未见此保护作用。结论提示fCPAP可能预防OSA患者的eGFR下降。

要点

  • 基线eGFR高于中位数(91.42 mL/min/1.73 m2)的OSA患者eGFR下降更显著。
  • 固定压力CPAP可减轻或消除eGFR下降,自动调节CPAP未见此保护作用。
  • 随访超过中位数(541天)时,未治疗和APAP组eGFR下降,fCPAP组无下降。

核心结论

  • 固定压力CPAP可能预防OSA患者的eGFR下降,而自动调节CPAP未见此效果。

研究设计与样本

  • 基于欧洲睡眠呼吸暂停数据库前瞻性队列,纳入未治疗患者144例、固定压力CPAP组1178例、自动调节CPAP组485例。
  • 用慢性肾脏病流行病学协作方程计算随访前后的eGFR。

主要发现

  • 全体样本eGFR随时间下降,基线eGFR高于中位数(91.42 mL/min/1.73 m2)者下降速率显著更高(P < .0001)。
  • fCPAP治疗可减轻或消除eGFR下降(P < .0001)。
  • 随访超过中位数(541天)与未治疗组和APAP组eGFR下降相关,fCPAP组无此关联(双因素方差分析交互作用P < .0001)。
  • 多因素回归中,高龄、女性、心力衰竭、较高基线eGFR和较长随访时间加剧eGFR下降,fCPAP具保护作用。

临床怎么用

  • 对OSA合并肾功能关注的患者,选择固定压力CPAP可能有助于减缓eGFR下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of treating OSA on renal function decline is controversial. Previous studies usually included small samples and did not consider specific effects of different CPAP modalities. The aim of this study was to evaluate the respective influence of fixed and autoadjusting CPAP modes on estimated glomerular filtration rate (eGFR) in a large sample of patients derived from the prospective European Sleep Apnea Database cohort. METHODS: In patients of the European Sleep Apnea Database, eGFR prior to and after follow-up was calculated by using the Chronic Kidney Disease-Epidemiology Collaboration equation. Three study groups were investigated: untreated patients (n = 144), patients receiving fixed CPAP (fCPAP) (n = 1,178), and patients on autoadjusting CPAP (APAP) (n = 485). RESULTS: In the whole sample, eGFR decreased over time. The rate of eGFR decline was significantly higher in the subgroup with eGFR above median (91.42 mL/min/1.73 m2) at baseline (P < .0001 for effect of baseline eGFR). This decline was attenuated or absent (P < .0001 for effect of treatment) in the subgroup of patients with OSA treated by using fCPAP. A follow-up duration exceeding the median (541 days) was associated with eGFR decline in the untreated and APAP groups but not in the fCPAP group (P < .0001 by two-way ANOVA for interaction between treatment and follow-up length). In multiple regression analysis, eGFR decline was accentuated by advanced age, female sex, cardiac failure, higher baseline eGFR, and longer follow-up duration, whereas there was a protective effect of fCPAP. CONCLUSIONS: fCPAP but not APAP may prevent eGFR decline in OSA.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Marrone O, Cibella F, Pépin JL, et al. Fixed But Not Autoadjusting Positive Airway Pressure Attenuates the Time-dependent Decline in Glomerular Filtration Rate in Patients With OSA. Chest. 2018. PMID: 29698721. doi:10.1016/j.chest.2018.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。